Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Pycnogenol, a standardized extract from the French maritime pine bark (Pinus pinaster), has been the subject of several clinical studies investigating its effects on circulation, especially in the context of chronic venous insufficiency (CVI) and other vascular disorders. The evidence supporting its use is primarily scientific and moderately robust. Randomized controlled trials have shown that Pycnogenol supplementation can improve symptoms such as leg heaviness, edema, and pain in patients with CVI. Its mechanisms of action are thought to involve antioxidative effects, strengthening of capillary walls, reduction of capillary permeability, and anti-inflammatory properties.

Meta-analyses and systematic reviews of clinical trials suggest that Pycnogenol is effective in reducing edema and improving microcirculation. For example, a 2012 meta-analysis in "Phytotherapy Research" concluded that Pycnogenol significantly improved symptoms of CVI compared to placebo. Additional studies have reported enhanced endothelial function and improved blood flow parameters in both healthy subjects and those with vascular disorders.

While more large-scale studies are needed to confirm its efficacy and safety for broader populations, current research supports the use of Pycnogenol as a valid adjunct in the management of poor circulation, particularly for venous disorders. Regulatory agencies in some countries recognize its benefits for vascular health, although it is generally marketed as a dietary supplement rather than a medication.

More about Pycnogenol
More about Circulation (poor)

Other ingredients used for Circulation (poor)

Other health conditions supported by Pycnogenol

Products containing Pycnogenol